Atlas Trials

Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP

Clinical trial NCT03542149 · COMPLETED

Trial details

NCT number
NCT03542149
Sponsor
Medicines for Malaria Venture
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria
Start date
2018-04-23
Primary completion
2019-04-19
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.